Asian Stocks Mixed Amid US Market Gains and Fed Rate Watch
Global markets experienced a subdued trading session on Thursday, largely due to the Christmas holiday closures impacting numerous exchanges worldwide. Trading volumes remained exceptionally light as markets closed early in anticipation of the Christmas Eve and Christmas observances. The Nikkei 225 in Tokyo provided a notable upward trend, rising by 0.1% to close at 50,407.79, marking nearly 30% gains for the year. Concurrently, the Chinese mainland composite index advanced by 0.5% to 3,959.62, while the euro strengthened against the Japanese yen, climbing to $1.1786 from $1.1780.
Several key developments shaped the day’s market activity. The People’s Bank of China issued a statement reaffirming its commitment to maintaining an adequate money supply to support economic growth and inflation targets, following a previous decision to hold steady on its key short-term lending rates. This intervention signaled further support for the Chinese economy. Meanwhile, in the United States, the S&P 500 index rose 0.3% to 6,932.05, and the Dow Jones Industrial Average increased by 0.6% to close at 48,731.16, with the Nasdaq composite adding 0.2% to 23,613.31. These gains reflect continued investor optimism, partly fueled by the perception of favorable deregulatory policies stemming from the previous administration and growing confidence in the potential of artificial intelligence to drive corporate profitability.
The focus of investors shifted toward upcoming economic data releases and the anticipated January meeting of the Federal Reserve. The market is largely betting on a pause in interest rate hikes by the Fed, although the precise direction of monetary policy remains a key point of discussion. The U.S. economy demonstrated surprising strength in the third quarter, expanding at a 4.3% annual rate, aided by persistent consumer spending despite inflationary pressures. However, emerging concerns regarding consumer confidence, a softening labor market, and weakening retail sales cast a shadow on the outlook. Recent data revealed diminished consumer confidence levels, fueled by anxieties about rising prices, alongside reports of a slowdown in the labor market.
Furthermore, the weekly unemployment benefit claims data offered a mixed picture. Applications for jobless claims fell by 10,000 to 214,000, below analysts’ forecasts, indicating a still-healthy labor market despite signs of deceleration. This positive data contributed to the overall market gains, though concerns about potential labor market weakness persisted. The day’s trading also witnessed notable corporate news. Dynavax Technologies experienced a dramatic surge of 38.2% after Sanofi announced its acquisition of the vaccine maker for $2.2 billion, including the potential addition of Dynavax’s hepatitis B vaccines and a shingles vaccine still in development.
Novo Nordisk shares rose 1.8% following regulatory approval from the U.S. for its Wegovy weight-loss drug in pill form, a significant step for the pharmaceutical giant. Despite this positive development, Novo Nordisk shares had experienced almost 40% declines year-to-date due to increased competition within the weight-loss medication market, particularly from Eli Lilly, whose shares had increased by almost 40% during the same period. Finally, crude oil prices closed at $58.35 per barrel for U.S. crude and $61.80 a barrel for Brent crude, reflecting continued global supply dynamics.
